Marisa Guitart Amechazurra

Founder/Executive Advisor-MGA Business Consulting /Venture Partner at Asabys Partners / Executive Advisor at Orikine Bio, Board Observer at BioSmartData, /+35 years in Life Sciences sector

📍 Greater Barcelona Metropolitan Area, Spain🔄 Updated September 2026💼 6 investments📅 14 years investing🗓 Last invested Jun 2022
VC🌍 Spain
6
Total investments
0
Early stage
1
Mid stage
3
Late stage
14y
Years active

Portfolio

5 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
Jun 2022
CIRCE Scientific is an emerging ingredient company focused on utilizing cocrystal technology to enhance properties such as greater bioavailability, stability, and solubility for nutraceutical and cosmetic applications. The company was founded in 2012, essentially focused on performing crystal engineering research of pharmaceutical compounds for pharma companies. Since 2017 we have developed our own pipeline of optimised active ingredients for longevity and healthy ageing. By applying our proprietary crystal engineering platform, we aim to dramatically optimize the health benefits of known active ingredients such as pterostilbene, ubiquinol, sitosterol and vitamin D, in order to develop innovative products in emerging health and longevity markets. Product application is broad and can be also used in the sport and pet industries. Our headquarters are based in Mallorca, additional offices and laboratories in the Barcelona Scientific Park.
Investor & Lead and representative of syndicate of investor's - MGA group for Mutter Ventures
Jan 2022
We are a Venture Builder born in 2018 in Barcelona (Spain). We operate as a publicly held company, focusing on the creation of startups in the FinTech, Software, IoT and Consumer sectors. We are a group of people with very different backgrounds and diverse profiles, shaping a multidisciplinary team with the ability to create startups and new businesses. Our operations range from creating our own ideas to building joint ventures and securing financial assistance with one guiding objective: to centralize all the elements and resources that a new venture needs to succeed.
Investor & Lead Investor of MGA group for Inbiomotion
Apr 2018
Inbiomotion SL is a research company based out of Spain.
late stageResearch
Business Angel
Mar 2014
Bioservo is a technology and development company that combines medical science with modern robotics. The company has a leading global position within soft exoskeleton technology, wearable non-invasive products, for people in need of extra power to support the bodys endurance and performance, or for people with reduced muscular strength. After many years of research and development, Bioservo now focus on the commercialization of its products and patented technologies. The developed gloves are well suited for both rehabilitation within health and medical care and preventively for professionals in the industry. The company has signed strategic cooperation agreements with several multinational companies within e.g. the automobile, aircraft as well as the construction and infrastructure industry. The technology was invented in 2006 through a collaboration between researchers at the Royal Institute of Technology and doctors at Karolinska University hospital in Stockholm. Bioservo AB is a Swedish company with headquarters and operations in Kista, north of Stockholm. For more information, please visit www.bioservo.com
Experience · 16 entries
All (16)
Investments (6)
Founder (2)
Board (1)
2023
Venture Partner
Apr 2023
Asabys Partners is a venture capital firm from Barcelona investing across the board in human healthcare. We are active in the health-tech and biopharma industries and aim to invest in Spain and abroad in highly innovative and transformative technologies. We are motivated by the idea of pushing the boundaries of science and medicine. We do this through the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry. We have an entrepreneurial spirit and seek to be involved in the building and management of our companies. Not just investors, we consider ourselves as partners and collaborators to our portfolio companies.
2022
Angel Investor
Jun 2022
CIRCE Scientific is an emerging ingredient company focused on utilizing cocrystal technology to enhance properties such as greater bioavailability, stability, and solubility for nutraceutical and cosmetic applications. The company was founded in 2012, essentially focused on performing crystal engineering research of pharmaceutical compounds for pharma companies. Since 2017 we have developed our own pipeline of optimised active ingredients for longevity and healthy ageing. By applying our proprietary crystal engineering platform, we aim to dramatically optimize the health benefits of known active ingredients such as pterostilbene, ubiquinol, sitosterol and vitamin D, in order to develop innovative products in emerging health and longevity markets. Product application is broad and can be also used in the sport and pet industries. Our headquarters are based in Mallorca, additional offices and laboratories in the Barcelona Scientific Park.
Investor & Lead and representative of syndicate of investor's - MGA group for Mutter Ventures
Jan 2022
We are a Venture Builder born in 2018 in Barcelona (Spain). We operate as a publicly held company, focusing on the creation of startups in the FinTech, Software, IoT and Consumer sectors. We are a group of people with very different backgrounds and diverse profiles, shaping a multidisciplinary team with the ability to create startups and new businesses. Our operations range from creating our own ideas to building joint ventures and securing financial assistance with one guiding objective: to centralize all the elements and resources that a new venture needs to succeed.
2019
2018
Investor & Lead Investor of MGA group for Inbiomotion
Apr 2018
Inbiomotion SL is a research company based out of Spain.
late stageResearch
Show all 16 entries ↓
Investment activity
2012–2022 · 6 investments
2012120141201812019120222
Recent (last 2 years)Earlier